Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Cell Genesys commences phase II trial of GVAX vaccine for pancreatic cancer

Oct. 23, 2001

CPMP issues positive opinion regarding MabThera for treatment of aggressive NHL

Oct. 22, 2001

Phase II clinical trials commence with Transgene's immunotherapeutic for cervical cancer

Oct. 19, 2001

InterMune and Boehringer Ingelheim expand partnership to develop product for ovarian cancer

Oct. 18, 2001

Oncophage enters fast track development

Oct. 16, 2001

New clinical data show Multikine's ability to eliminate HPV-induced cervical dysplasia

Oct. 15, 2001

Favorable OvaRex/chemotherapy clinical trial results in relapsed ovarian cancer reported by AltaRex

Oct. 15, 2001

Fully humanized antibody for diagnosis and therapy of cancer

Oct. 10, 2001

Lorus and Faulding establish Virulizin distribution agreement for Latin America

Oct. 10, 2001

FDA grants orphan drug designation to Celgene's Revimid for multiple myeloma

Oct. 9, 2001

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...